Lupin’s US arm receives the 2011 DIANA award

Lupin’s subsidiary Lupin Pharmaceutical has received the 2011 DIANA award by the Healthcare Distribution Management Association (HDMA) for the best overall generic product manufacturing among those companies with the sale of up to $100 million in the healthcare distribution market.

HDMA distributor members selected the DIANA award winners to recognize companies that continually foster strong trading partner relationship with the Association’s primary distributor members by creating exceptional business practices that advance trade relationship and benefit the entire US healthcare supply chain.

Lupin is an innovation led transnational pharmaceutical company producing wide range of quality, affordable generic and branded formulations and API’s. Currently the company has significant presence in the cardiovascular, diabetology, asthma, pediatrics, CNS, CI, anti infective, NSAIDs addition to holding global leadership position in the anti TB and cephalosporins space.